AVENUE THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Avenue Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Avenue Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $35.7M, a 15.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $35.7M +$4.7M +15.2% Dec 31, 2023 10-K 2024-03-18
Q4 2022 $31M +$3.15M +11.3% Dec 31, 2022 10-K 2024-03-18
Q4 2021 $27.8M +$881K +3.27% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $26.9M +$2.08M +8.35% Dec 31, 2020 10-K 2022-03-25
Q4 2019 $24.9M +$11.5M +86.4% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $13.3M +$7.6M +132% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $5.74M +$2.42M +73.1% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $3.32M Dec 31, 2016 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.